About
- Leadership
  - Executive Team
  - Board of Directors
- Facilities
Therapeutic Areas Overview
Pipeline
Clinical Trials
News & Events
Investors
Careers
Contact Us

Tonix is enrolling in a Phase 3 study for Fibromyalgia, and Phase 2 studies for Long COVID, Chronic Migraine, and Major Depressive Disorder. Please visit Clinical Trials.

IR Events

Investors

Overview
News & Events
Presentations
Multimedia
Financial Info
Stock Data
SEC Filings
Governance

News & Events
Tonix in the News
Press Releases
IR Events
Email Alerts
Op-Eds

Long COVID: What Will it Take to Accelerate Therapeutic Progress?

Feb 21, 2023 1:00 pm EDT – 4:30 pm EDT

Webcast

Audio

Sign up for Email Alerts

Contact Us
Privacy Policy
Terms of Use
Site Map

© 2023 Tonix Pharmaceuticals Holding Corp.